Kitonail

Ciclopirox, the active ingredient in Kitonail, is an antifungal presented as a topical formulation for external use. It treats fungal infections of the skin, nails and mucous membranes in both adults and children.

GNH USA supplies Kitonail as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Kitonail is manufactured under EU GMP guidelines, ensuring consistent potency and safety across batches. Clients benefit from comprehensive regulatory support and after‑sales service.

Ciclopirox is used to treat fungal skin and nail infections by inhibiting fungal growth.

Tinea pedis: alleviates itching, scaling and redness by reducing dermatophyte proliferation. Tinea corporis: clears ring‑shaped lesions and prevents spread of infection. Tinea cruris: relieves groin rash and limits fungal colonisation. Onychomycosis: improves nail appearance and reduces fungal load in infected nails. Candidiasis: treats cutaneous candidal eruptions and reduces yeast overgrowth.

Topical ciclopirox may cause local skin reactions, ranging from mild irritation to rare severe responses.

Common Side Effects: - Local irritation: mild burning or stinging at the application site. - Itching: transient pruritus around treated area. - Redness: erythema of the skin. - Dryness: peeling or flaking of the skin. - Scaling: slight desquamation.

Serious or Rare Side Effects: - Allergic contact dermatitis: rash, swelling, vesicles, and itching that may require discontinuation. - Severe skin irritation: intense burning, ulceration, or necrosis. - Angioedema: swelling of lips, face or throat. - Anaphylactic reaction: systemic signs such as hives, difficulty breathing, and hypotension.

Before using Kitonail, consider the following precautions to ensure safe and effective treatment. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: use with caution; potential exposure to infant is unknown. - Age: follow label instructions; pediatric safety not fully established for all ages. - Application site: avoid eyes, mucous membranes and broken skin. - Allergy: discontinue use and seek medical advice if severe skin reaction occurs. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Ciclopirox can interact with other topical agents or systemic medications, affecting efficacy or safety.

Major Interactions (Avoid): - Concurrent use with other topical antifungals: may increase local irritation. - Application under occlusive dressings: risk of heightened absorption and skin irritation. - Combination with systemic antifungal therapy: potential additive toxicity.

Moderate Interactions (Monitor Closely): - Use with alcohol‑based skin products: may reduce drug stability. - Co‑application with topical corticosteroids: could diminish antifungal effect. - Concomitant chemotherapy: monitor for enhanced skin toxicity.